Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | E2F4 |
| Upstream (Parents) |
|---|
| (<<) IL23A → E2F4 |
| (<<) MAP3K10 → E2F4 |
| (<<) RPS12 → E2F4 |
| (<<) SEMA5B → E2F4 |
| (<<) SLC34A3 → E2F4 |
| Downstream (Children) |
|---|
| E2F4 → ARID3B (>>) |
| E2F4 → ATN1 (>>) |
| E2F4 → ATP10B (>>) |
| E2F4 → B3GNT3 (>>) |
| E2F4 → CDH22 (>>) |
| E2F4 → CYP1A2 (>>) |
| E2F4 → CYP4F2 (>>) |
| E2F4 → FGFBP1 (>>) |
| E2F4 → GOT2 (>>) |
| E2F4 → MAPK7 (>>) |
| E2F4 → PAK4 (>>) |
| E2F4 → PSORS1C2 (>>) |
| E2F4 → SPRR2G (>>) |
| E2F4 → TMC7 (>>) |
| E2F4 → VAC14 (>>) |
| E2F4 → WNT6 (>>) |
